These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18650331)

  • 1. Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements.
    Liang L; DeLong MR; Papa SM
    J Neurosci; 2008 Jul; 28(30):7537-47. PubMed ID: 18650331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates.
    Singh A; Liang L; Kaneoke Y; Cao X; Papa SM
    J Neurophysiol; 2015 Mar; 113(5):1533-44. PubMed ID: 25505120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
    Perez XA; Zhang D; Bordia T; Quik M
    Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia.
    Ryan MB; Bair-Marshall C; Nelson AB
    Cell Rep; 2018 Jun; 23(12):3438-3446.e5. PubMed ID: 29924988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia.
    Nadjar A; Brotchie JM; Guigoni C; Li Q; Zhou SB; Wang GJ; Ravenscroft P; Georges F; Crossman AR; Bezard E
    J Neurosci; 2006 Aug; 26(34):8653-61. PubMed ID: 16928853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
    Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R
    Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism.
    Deutch AY; Colbran RJ; Winder DJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3(Suppl 3):S251-8. PubMed ID: 18267246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats.
    Soderstrom KE; O'Malley JA; Levine ND; Sortwell CE; Collier TJ; Steece-Collier K
    Eur J Neurosci; 2010 Feb; 31(3):478-90. PubMed ID: 20105237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease.
    Kim W; Im MJ; Park CH; Lee CJ; Choi S; Yoon BJ
    Neurosci Lett; 2013 Dec; 557 Pt B():95-100. PubMed ID: 24176882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum.
    Alberico SL; Kim YC; Lence T; Narayanan NS
    Neuroscience; 2017 Feb; 343():240-249. PubMed ID: 27956068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.
    Warre R; Thiele S; Talwar S; Kamal M; Johnston TH; Wang S; Lam D; Lo C; Khademullah CS; Perera G; Reyes G; Sun XS; Brotchie JM; Nash JE
    Neurobiol Dis; 2011 Mar; 41(3):591-604. PubMed ID: 20971190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
    Cerovic M; Bagetta V; Pendolino V; Ghiglieri V; Fasano S; Morella I; Hardingham N; Heuer A; Papale A; Marchisella F; Giampà C; Calabresi P; Picconi B; Brambilla R
    Biol Psychiatry; 2015 Jan; 77(2):106-15. PubMed ID: 24844602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    Sellnow RC; Steece-Collier K; Altwal F; Sandoval IM; Kordower JH; Collier TJ; Sortwell CE; West AR; Manfredsson FP
    J Neurosci; 2020 Apr; 40(18):3675-3691. PubMed ID: 32238479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
    Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
    J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N; Martín AB; Mendialdua A; Moratalla R
    Biol Psychiatry; 2006 Jan; 59(1):64-74. PubMed ID: 16139809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
    Boraud T; Bezard E; Bioulac B; Gross CE
    Brain; 2001 Mar; 124(Pt 3):546-57. PubMed ID: 11222455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.
    Bankiewicz KS; Daadi M; Pivirotto P; Bringas J; Sanftner L; Cunningham J; Forsayeth JR; Eberling JL
    Exp Neurol; 2006 Feb; 197(2):363-72. PubMed ID: 16337943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.